
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **IGF2 (Insulin-like Growth Factor 2):** Involved in growth and development, often associated with cancer proliferation.<br>- **COL2A1 (Collagen Type II Alpha 1 Chain):** Typically associated with cartilage formation, but can be expressed in certain cancer types.<br>- **PTGDS (Prostaglandin D2 Synthase):** Involved in prostaglandin synthesis, which can play a role in inflammation and cancer.<br>- **HSPB6 (Heat Shock Protein Family B Member 6):** A small heat shock protein involved in stress response.<br>- **SNAI2 (Snail Family Transcriptional Repressor 2):** A transcription factor involved in epithelial-mesenchymal transition (EMT), a process important in cancer metastasis.<br>- **FABP5 (Fatty Acid Binding Protein 5):** Involved in fatty acid metabolism, often upregulated in cancer.<br>- **VIM (Vimentin):** A marker of mesenchymal cells, often upregulated during EMT in cancer.<br><br>### Step 2: List the Key Cell Type Markers<br>- **ACAN (Aggrecan):** Typically a marker for chondrocytes, but can be expressed in certain cancer contexts.<br>- **BGN (Biglycan):** A small leucine-rich repeat proteoglycan, often associated with the extracellular matrix and cancer.<br>- **CRABP1 (Cellular Retinoic Acid Binding Protein 1):** Involved in retinoic acid signaling, which can influence cell differentiation and cancer.<br>- **S100A1 (S100 Calcium Binding Protein A1):** Often expressed in various cell types, including some cancer cells.<br>- **SDC2 (Syndecan 2):** A cell surface proteoglycan involved in cell adhesion and signaling, often upregulated in cancer.<br>- **CHI3L1 (Chitinase 3 Like 1):** Involved in tissue remodeling and inflammation, often upregulated in cancer.<br>- **NDRG1 (N-Myc Downstream Regulated 1):** Involved in stress response and cell differentiation, often associated with cancer progression.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers to identify potential cell types. Many of these markers are associated with mesenchymal cells, cancer-associated fibroblasts (CAFs), and cells undergoing EMT.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Given the expression of markers like VIM, SNAI2, and others associated with EMT and mesenchymal characteristics, the most probable general cell type is **cancer-associated fibroblasts (CAFs)** or **mesenchymal cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Cancer-Associated Fibroblasts (CAFs):** Given the expression of VIM, SNAI2, and other markers associated with the tumor microenvironment and ECM remodeling.<br>2. **Mesenchymal Stem Cells (MSCs):** Due to the expression of markers like VIM and COL2A1, which are often found in mesenchymal lineages.<br>3. **Myofibroblasts:** These cells are involved in wound healing and fibrosis, often expressing markers like VIM and S100A1.<br><br>The most likely subtype based on the markers is **Cancer-Associated Fibroblasts (CAFs)**, given their role in the tumor microenvironment and the expression of several ECM-related and EMT markers.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of cancer-associated fibroblasts (CAFs). This conclusion is supported by the expression of markers associated with mesenchymal characteristics, ECM remodeling, and EMT, which are typical of CAFs in the tumor microenvironment. The top three probable subtypes considered were CAFs, mesenchymal stem cells, and myofibroblasts, with CAFs being the most likely due to their prominent role in cancer progression and the specific marker expression profile observed.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The markers used in the annotation (e.g., IGF2, COL2A1, PTGDS, HSPB6, SNAI2, FABP5, VIM, ACAN, BGN, CRABP1, S100A1, SDC2, CHI3L1, NDRG1) are present in the provided marker list.<br>   - The markers are consistent with the identified cell type, cancer-associated fibroblasts (CAFs), and mesenchymal cells. Markers like VIM, SNAI2, and others are well-known to be associated with mesenchymal characteristics and the tumor microenvironment, supporting the annotation of CAFs.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The analysis considers the possibility of mixed cell types by identifying potential subtypes such as mesenchymal stem cells and myofibroblasts. However, the strongest support is for CAFs, given the expression of several high-ranking markers associated with this cell type.<br>   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for further investigation.<br><br>Overall, the annotation is well-supported by the marker list and the context provided, leading to a valid conclusion of cancer-associated fibroblasts as the primary cell type.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">cancer-associated fibroblasts (CAFs)</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>mesenchymal stem cells (MSCs)</li><li>myofibroblasts</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough analysis of the marker list, with a focus on identifying the most probable cell type and subtypes. The analysis correctly identifies cancer-associated fibroblasts (CAFs) as the main cell type, which is consistent with the expression of markers such as VIM, SNAI2, and others associated with mesenchymal characteristics and the tumor microenvironment. This is a scientifically accurate conclusion given the context of breast cancer tissue.<br><br>The annotation process shows a balanced consideration of multiple markers, rather than over-focusing on a specific one. For instance, the analysis includes markers like IGF2, COL2A1, PTGDS, and others, which are relevant to cancer biology and mesenchymal characteristics. The use of databases like the Human Protein Atlas and CellMarker to cross-reference these markers adds credibility to the annotation.<br><br>The annotation captures the general picture of the cell populations by considering potential subtypes such as mesenchymal stem cells (MSCs) and myofibroblasts. This indicates an understanding of the complexity and heterogeneity of the tumor microenvironment. However, the analysis could have been strengthened by discussing the rank of the markers more explicitly, as markers appearing earlier in the list might have more significance.<br><br>There are no obvious misclassifications or oversights in the annotation. The analysis is comprehensive and considers the possibility of mixed cell types, although it concludes that CAFs are the predominant type. This conclusion is well-supported by the marker list and the context provided.<br><br>Overall, the annotation is scientifically accurate, balanced in its use of markers, and provides a comprehensive view of the cell types present. The analysis is well-reasoned and captures the general picture effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    